ID   Hepa 1-6
AC   CVCL_0327
SY   HEPA 1-6; Hepa-1-6; Hepa1-6
DR   BTO; BTO:0002895
DR   CLO; CLO_0003711
DR   CLO; CLO_0050769
DR   MCCL; MCC:0000223
DR   CLDB; cl1658
DR   CLDB; cl1659
DR   CLDB; cl5199
DR   AddexBio; C0015005/4999
DR   ATCC; CRL-1830
DR   BCRC; 60051
DR   BioSample; SAMN11397636
DR   CCRID; 3111C0001CCC000106
DR   CCRID; 3131C0001000800030
DR   CCRID; 3142C0001000000339
DR   CCTCC; GDC0313
DR   CLS; 400474/p731_Hepa_1-6
DR   DSMZ; ACC-175
DR   ECACC; 92110305
DR   GEO; GSM1374085
DR   GEO; GSM1374086
DR   GEO; GSM1374087
DR   GEO; GSM1374088
DR   GEO; GSM1374089
DR   GEO; GSM1374090
DR   IZSLER; BS TCL 157
DR   Lonza; 830
DR   NCBI_Iran; C517
DR   PRIDE; PXD001792
DR   RCB; RCB1638
DR   Wikidata; Q54882820
RX   PubMed=25193168;
RX   PubMed=26280412;
RX   PubMed=28152020;
RX   PubMed=31220119;
WW   http://www.cellresource.cn/fdetail.aspx?id=106
WW   http://www.cellresource.cn/fdetail.aspx?id=753
WW   http://www.cellresource.cn/fdetail.aspx?id=1990
CC   Doubling time: 26.99 +- 1.93 hours (PubMed=28152020); ~30 hours (DSMZ).
CC   Omics: Deep phosphoproteome analysis.
CC   Omics: Deep proteome analysis.
CC   Omics: Transcriptome analysis.
CC   Breed/subspecies: C57L.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 14,15,16
ST   Mouse STR 1-2: 13
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17.1
ST   Mouse STR 15-3: 17,18,19
ST   Mouse STR 17-2: 14
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 10,11
ST   Mouse STR 2-1: 14
ST   Mouse STR 3-2: 10
ST   Mouse STR 4-2: 18.3,19.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 15
ST   Mouse STR X-1: 25
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_S550 ! Hepa-1
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-19; Version: 19
//
RX   PubMed=25193168; DOI=10.1074/mcp.M113.037291;
RA   Hornburg D., Drepper C., Butter F., Meissner F., Sendtner M., Mann M.;
RT   "Deep proteomic evaluation of primary and cell line motoneuron disease
RT   models delineates major differences in neuronal characteristics.";
RL   Mol. Cell. Proteomics 13:3410-3420(2014).
//
RX   PubMed=26280412; DOI=10.1038/nbt.3327;
RA   Humphrey S.J., Azimifar S.B., Mann M.;
RT   "High-throughput phosphoproteomics reveals in vivo insulin signaling
RT   dynamics.";
RL   Nat. Biotechnol. 33:990-995(2015).
//
RX   PubMed=28152020; DOI=10.1371/journal.pone.0171215;
RA   Lacoste B., Raymond V.-A., Cassim S., Lapierre P., Bilodeau M.;
RT   "Highly tumorigenic hepatocellular carcinoma cell line with cancer
RT   stem cell-like properties.";
RL   PLoS ONE 12:E0171215-E0171215(2017).
//
RX   PubMed=31220119; DOI=10.1371/journal.pone.0218412;
RA   Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S.,
RA   Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H.,
RA   Li J., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B.,
RA   Natoli M., Bauer B., Gollin S.M., Lewis D.W., Reid Y.A.;
RT   "Interlaboratory study to validate a STR profiling method for
RT   intraspecies identification of mouse cell lines.";
RL   PLoS ONE 14:E0218412-E0218412(2019).
//